PAPER Sen D, Rathee S, Pandey V, Jain SK, Patil UK
SEARCH RESULTS
330959 RESULTS
PAPER Alty J, Goldberg LR, Roccati E, Lawler K, Bai Q, Huang G, Bindoff AD, Li R, Wang X, St George RJ, Rudd K, Bartlett L, Collins JM, Aiyede M, Fernando N, Bhagwat A, Giffard J, Salmon K, McDonald S, King AE, Vickers JC
Development of a smartphone screening test for preclinical Alzheimer's disease and validation across the dementia continuum.
BMC Neurol. 2024 Apr 16;24(1):127. PubMed: 38627686PAPER Inci OK, Basırlı H, Can M, Yanbul S, Seyrantepe V
Gangliosides as Therapeutic Targets for Neurodegenerative Diseases.
J Lipids. 2024;2024:4530255. Epub 2024 Apr 8 PubMed: 38623278PAPER Lee C, Friedman A
Generating PET scan patterns in Alzheimer's by a mathematical model.
PLoS One. 2024;19(4):e0299637. Epub 2024 Apr 16 PubMed: 38625863PAPER Magrì A, Lipari CL, Caccamo A, Battiato G, Conti Nibali S, De Pinto V, Guarino F, Messina A
AAV-mediated upregulation of VDAC1 rescues the mitochondrial respiration and sirtuins expression in a SOD1 mouse model of inherited ALS.
Cell Death Discov. 2024 Apr 16;10(1):178. PubMed: 38627359PAPER Patwa J, Flora SJ
Copper: From enigma to therapeutic target for neurological disorder.
Basic Clin Pharmacol Toxicol. 2024 Apr 15; PubMed: 38622813PAPER Hamad AA, Amer BE
Safety of masitinib in patients with neurodegenerative diseases: a meta-analysis of randomized controlled trials.
Neurol Sci. 2024 Apr 17; PubMed: 38627298PAPER Zhou B, Zhao Y, Wu X
Differences of individual gray matter networks between MCI patients who converted to AD within 3 Years and nonconverters.
Heliyon. 2024 Apr 15;10(7):e28874. Epub 2024 Mar 29 PubMed: 38623255PAPER Jo MG, Ikram M, Jo MH, Yoo L, Chung KC, Nah SY, Hwang H, Rhim H, Kim MO
Retraction Note: Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.
Mol Neurobiol. 2024 Apr 16; PubMed: 38625622PAPER Liu Z, Shi D, Cai Y, Li A, Lan G, Sun P, Liu L, Zhu Y, Yang J, Zhou Y, Guo L, Zhang L, Deng S, Chen S, Yu X, Chen X, Zhao R, Wang Q, Ran P, Xu L, Zhou L, Sun K, Wang X, Peng Q, Han Y, Guo T
Pathophysiology characterization of Alzheimer's disease in South China's aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS).
Alzheimers Res Ther. 2024 Apr 16;16(1):84. PubMed: 38627753PAPER Kovalová M, Gottfriedová N, Mrázková E, Janout V, Janoutová J
Cognitive impairment, neurodegenerative disorders, and olfactory impairment: A literature review.
Otolaryngol Pol. 2024 Apr 9;78(2):1-17. PubMed: 38623856PAPER Savant R, Pradhan RK, Bhagat S, Mythri RB, Varghese AM, Vengalil S, Nalini A, Sathyaprabha TN, Raju TR, Vijayalakshmi K
Enhanced Levels of Fractalkine and HSP60 in Cerebrospinal Fluid of Sporadic Amyotrophic Lateral Sclerosis Patients.
Int J Neurosci. 2024 Apr 16;:1-14. PubMed: 38625841PAPER Taufik SA, Ramli N, Tan AH, Lim SY, Ghani MT, Shahrizaila N
Longitudinal Changes in the Retinal Nerve Fiber Layer Thickness in Amyotrophic Lateral Sclerosis and Parkinson's Disease: A Comparative Study.
J Clin Neurol. 2024 Apr 2; PubMed: 38627230PAPER Barel D, Marom D, Ponger P, Kurolap A, Bar-Shira A, Kaplan-Ber I, Mory A, Abramovich B, Yaron Y, Drory V, Baris Feldman H
Genetic diagnosis and detection rates using C9orf72 repeat expansion and a multi-gene panel in amyotrophic lateral sclerosis.
J Neurol. 2024 Apr 16; PubMed: 38625400PAPER Ikari Y, Akamatsu G, Matsumoto K, Yamane T, Senda M, Fukuchi K, AMED Preclinical AD Study Investigators, and Alzheimer’s Disease Neuroimaging Initiative Investigators
Improved Correlation of 18F-Flortaucipir PET SUVRs and Clinical Stages in the Alzheimer Disease Continuum with the MUBADA/PERSI-Based Analysis.
J Nucl Med Technol. 2024 Apr 16; PubMed: 38627012Current Filters
No filters selected